Abcodia appoints Dr Wendy Alderton director of sciences
This article was originally published in Scrip
Abcodia, a discoverer of molecular biomarkers for disease diagnosis and screening, has appointed Dr Wendy Alderton director of science. Dr Alderton has experience of project management from GlaxoSmithKline, Millennium Pharmaceuticals, Piramed and Summit. Her areas of expertise include oncology, neuroscience and inflammation.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.